share_log

Altimmune | 4: Statement of changes in beneficial ownership of securities-Officer Harris Matthew Scott

SEC announcement ·  Feb 6 07:04
Summary by Futu AI
Matthew Scott Harris, Chief Medical Officer of Altimmune, Inc. [ALT], completed a series of stock transactions on February 1 and 2, 2024. Harris exercised options to acquire a total of 13,941 shares of common stock at no cost. Concurrently, he disposed of 4,133 shares to cover exercise prices or tax liabilities, with the sales priced between $9.32 and $9.88 per share, resulting in a total market value of $39,528.12. Following these transactions, Harris holds a total of 53,633 Altimmune shares directly.
Matthew Scott Harris, Chief Medical Officer of Altimmune, Inc. [ALT], completed a series of stock transactions on February 1 and 2, 2024. Harris exercised options to acquire a total of 13,941 shares of common stock at no cost. Concurrently, he disposed of 4,133 shares to cover exercise prices or tax liabilities, with the sales priced between $9.32 and $9.88 per share, resulting in a total market value of $39,528.12. Following these transactions, Harris holds a total of 53,633 Altimmune shares directly.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.